Intestinal strongyloidiasis: Recognition, management, and determinants of outcome

Ronald Concha, William Harrington, Arvey I. Rogers

Research output: Contribution to journalArticle

158 Citations (Scopus)

Abstract

Significant advances have occurred in our understanding of the biology, immunology, and immunopathology of the usually asymptomatic human infection by the intestinal parasite, Strongyloides stercoralis. Factors that increase the risk for the occurrence of symptomatic intestinal hyperinfection and/or often-fatal disseminated strongyloidiasis have been better defined. The pathophysiology underlying these risk factors, whether disease-related or iatrogenically induced, is a compromised immune system leading to dysfunction of TH-2 helper cells. These specialized lymphocytes are central to maintaining the delicate balance that exists between the infected human host and the stabilized parasite. Recognition of risk factors that impair the function of TH-2 lymphocytes is essential to heightening the index of clinical suspicion enhancing earlier, accurate diagnosis, and the introduction of appropriate therapy. This review summarizes what is understood about infection by S. stercoralis; its focus will be on the epidemiology, diagnosis, clinical presentation patterns in the immunocompetent and immunocompromised human hosts, and recommended treatment regimens.

Original languageEnglish
Pages (from-to)203-211
Number of pages9
JournalJournal of Clinical Gastroenterology
Volume39
Issue number3
DOIs
StatePublished - Mar 1 2005
Externally publishedYes

Fingerprint

Strongyloidiasis
Strongyloides stercoralis
Parasites
Lymphocytes
Th2 Cells
Asymptomatic Infections
Immunocompromised Host
Helper-Inducer T-Lymphocytes
Allergy and Immunology
Early Diagnosis
Immune System
Epidemiology
Infection
Therapeutics

Keywords

  • Diagnosis
  • Host immune competence
  • Intestinal strongyloidiasis
  • Risk factors
  • Treatment

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Intestinal strongyloidiasis : Recognition, management, and determinants of outcome. / Concha, Ronald; Harrington, William; Rogers, Arvey I.

In: Journal of Clinical Gastroenterology, Vol. 39, No. 3, 01.03.2005, p. 203-211.

Research output: Contribution to journalArticle

Concha, Ronald ; Harrington, William ; Rogers, Arvey I. / Intestinal strongyloidiasis : Recognition, management, and determinants of outcome. In: Journal of Clinical Gastroenterology. 2005 ; Vol. 39, No. 3. pp. 203-211.
@article{70b8c0bdc04e4f538900a7b24c19401c,
title = "Intestinal strongyloidiasis: Recognition, management, and determinants of outcome",
abstract = "Significant advances have occurred in our understanding of the biology, immunology, and immunopathology of the usually asymptomatic human infection by the intestinal parasite, Strongyloides stercoralis. Factors that increase the risk for the occurrence of symptomatic intestinal hyperinfection and/or often-fatal disseminated strongyloidiasis have been better defined. The pathophysiology underlying these risk factors, whether disease-related or iatrogenically induced, is a compromised immune system leading to dysfunction of TH-2 helper cells. These specialized lymphocytes are central to maintaining the delicate balance that exists between the infected human host and the stabilized parasite. Recognition of risk factors that impair the function of TH-2 lymphocytes is essential to heightening the index of clinical suspicion enhancing earlier, accurate diagnosis, and the introduction of appropriate therapy. This review summarizes what is understood about infection by S. stercoralis; its focus will be on the epidemiology, diagnosis, clinical presentation patterns in the immunocompetent and immunocompromised human hosts, and recommended treatment regimens.",
keywords = "Diagnosis, Host immune competence, Intestinal strongyloidiasis, Risk factors, Treatment",
author = "Ronald Concha and William Harrington and Rogers, {Arvey I.}",
year = "2005",
month = "3",
day = "1",
doi = "10.1097/01.mcg.0000152779.68900.33",
language = "English",
volume = "39",
pages = "203--211",
journal = "Journal of Clinical Gastroenterology",
issn = "0192-0790",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Intestinal strongyloidiasis

T2 - Recognition, management, and determinants of outcome

AU - Concha, Ronald

AU - Harrington, William

AU - Rogers, Arvey I.

PY - 2005/3/1

Y1 - 2005/3/1

N2 - Significant advances have occurred in our understanding of the biology, immunology, and immunopathology of the usually asymptomatic human infection by the intestinal parasite, Strongyloides stercoralis. Factors that increase the risk for the occurrence of symptomatic intestinal hyperinfection and/or often-fatal disseminated strongyloidiasis have been better defined. The pathophysiology underlying these risk factors, whether disease-related or iatrogenically induced, is a compromised immune system leading to dysfunction of TH-2 helper cells. These specialized lymphocytes are central to maintaining the delicate balance that exists between the infected human host and the stabilized parasite. Recognition of risk factors that impair the function of TH-2 lymphocytes is essential to heightening the index of clinical suspicion enhancing earlier, accurate diagnosis, and the introduction of appropriate therapy. This review summarizes what is understood about infection by S. stercoralis; its focus will be on the epidemiology, diagnosis, clinical presentation patterns in the immunocompetent and immunocompromised human hosts, and recommended treatment regimens.

AB - Significant advances have occurred in our understanding of the biology, immunology, and immunopathology of the usually asymptomatic human infection by the intestinal parasite, Strongyloides stercoralis. Factors that increase the risk for the occurrence of symptomatic intestinal hyperinfection and/or often-fatal disseminated strongyloidiasis have been better defined. The pathophysiology underlying these risk factors, whether disease-related or iatrogenically induced, is a compromised immune system leading to dysfunction of TH-2 helper cells. These specialized lymphocytes are central to maintaining the delicate balance that exists between the infected human host and the stabilized parasite. Recognition of risk factors that impair the function of TH-2 lymphocytes is essential to heightening the index of clinical suspicion enhancing earlier, accurate diagnosis, and the introduction of appropriate therapy. This review summarizes what is understood about infection by S. stercoralis; its focus will be on the epidemiology, diagnosis, clinical presentation patterns in the immunocompetent and immunocompromised human hosts, and recommended treatment regimens.

KW - Diagnosis

KW - Host immune competence

KW - Intestinal strongyloidiasis

KW - Risk factors

KW - Treatment

UR - http://www.scopus.com/inward/record.url?scp=14144250830&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=14144250830&partnerID=8YFLogxK

U2 - 10.1097/01.mcg.0000152779.68900.33

DO - 10.1097/01.mcg.0000152779.68900.33

M3 - Article

C2 - 15718861

AN - SCOPUS:14144250830

VL - 39

SP - 203

EP - 211

JO - Journal of Clinical Gastroenterology

JF - Journal of Clinical Gastroenterology

SN - 0192-0790

IS - 3

ER -